Scholar Rock Presents Additional Preclinical Data Demonstrating a Highly Specific Inhibitor of TGF?1 Activation Can Render Resistant Solid Tumors Vulnerable to PD1 Blockade and Drive Tumor Regression with Combination Therapy

0
1

Scholar Rock Presents Additional Preclinical Data Demonstrating a Highly Specific Inhibitor of TGF?1 Activation Can Render Resistant Solid Tumors Vulnerable to PD1 Blockade and Drive Tumor Regression with Combination Therapy

LEAVE A REPLY

Please enter your comment!
Please enter your name here